Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bernardo BC"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
Autorzy:
Bernardo BC; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Diabetes, Central Clinical School, Monash University, Clayton, VIC 3800, Australia.; Department of Paediatrics, University of Melbourne, Parkville, VIC 3010, Australia.
Yildiz GS; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Kiriazis H; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.
Harmawan CA; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Tai CMK; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Ritchie RH; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Royal Parade, Parkville, VIC 3052, Australia.
McMullen JR; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Diabetes, Central Clinical School, Monash University, Clayton, VIC 3800, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Physiology, Monash University, Clayton, VIC 3800, Australia.; Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 03; Vol. 11 (19). Date of Electronic Publication: 2022 Oct 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/genetics
MicroRNAs*/metabolism
Animals ; Blood Glucose ; Cardiomegaly/genetics ; Cardiomegaly/metabolism ; Disease Models, Animal ; Fibrosis ; Male ; Mice ; Mice, Inbred Strains ; Natriuretic Peptide, Brain ; Streptozocin ; Vinculin
Czasopismo naukowe
Tytuł:
Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.
Autorzy:
Horlock D; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Kaye DM; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Cardiology, Alfred Hospital, Melbourne, VIC 3004, Australia.; Department of Medicine, Monash University, Clayton, VIC 3800, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.
Winbanks CE; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
Gao XM; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Disease in Central Asia, Clinical Medical Research Institute of Xinjiang Medical University, Urumqi 830054, China.
Kiriazis H; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.
Donner DG; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.
Gregorevic P; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Centre for Muscle Research, Department of Physiology, University of Melbourne, Parkville, VIC 3010, Australia.
McMullen JR; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Medicine, Monash University, Clayton, VIC 3800, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC 3010, Australia.; Department of Diabetes, Central Clinical School, Monash University, Clayton, VIC 3800, Australia.; Department of Physiology, Monash University, Clayton, VIC 3800, Australia.; Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
Bernardo BC; Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Diabetes, Central Clinical School, Monash University, Clayton, VIC 3800, Australia.; Department of Paediatrics, University of Melbourne, VIC 3010, Australia.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Mar 15; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
Autorzy:
Bernardo BC; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Nguyen SS; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.; Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, 3086, Australia.
Gao XM; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Tham YK; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.; Monash University, Clayton, 3800, Australia.
Ooi JY; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Patterson NL; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Kiriazis H; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Su Y; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Thomas CJ; Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, 3086, Australia.
Lin RC; Asbestos Diseases Research Institute, Concorde Hospital, 2139, Australia.; Ramaciotti Centre for Genomics and School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, 2052, Australia.
Du XJ; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.; Monash University, Clayton, 3800, Australia.
McMullen JR; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.; Monash University, Clayton, 3800, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Mar 01; Vol. 6, pp. 22442. Date of Electronic Publication: 2016 Mar 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertrophy, Left Ventricular/*genetics
MicroRNAs/*antagonists & inhibitors
MicroRNAs/*genetics
Pulmonary Fibrosis/*genetics
Ventricular Remodeling/*genetics
Animals ; Aorta/surgery ; Atrial Natriuretic Factor/biosynthesis ; Cyclin-Dependent Kinase Inhibitor p15/biosynthesis ; Disease Models, Animal ; Echocardiography ; Hypertension/pathology ; Hypertrophy, Left Ventricular/drug therapy ; Hypertrophy, Left Ventricular/surgery ; Male ; Mice ; Mice, Inbred C57BL ; Natriuretic Peptide, Brain/biosynthesis ; Oligonucleotides/genetics ; Oligonucleotides/pharmacology ; Ventricular Remodeling/drug effects
Czasopismo naukowe
Tytuł:
Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation.
Autorzy:
Bernardo BC; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Sapra G; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Patterson NL; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Cemerlang N; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Kiriazis H; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Ueyama T; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Febbraio MA; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.; Garvan Institute of Medical Research, Darlinghurst, 2010, Australia.
McMullen JR; Baker IDI Heart and Diabetes Institute, Melbourne, 3004, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Dec 14; Vol. 10 (12), pp. e0145173. Date of Electronic Publication: 2015 Dec 14 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ventricular Remodeling*
Atrial Fibrillation/*physiopathology
HSP70 Heat-Shock Proteins/*metabolism
Heart Failure/*physiopathology
Heart Ventricles/*physiopathology
Animals ; Atrial Fibrillation/metabolism ; Chronic Disease ; Collagen Type I/metabolism ; Disease Models, Animal ; Electrocardiography ; Female ; Fibrosis ; HSP70 Heat-Shock Proteins/genetics ; Heart Failure/metabolism ; Heart Ventricles/metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Transgenic ; Muscle Proteins/genetics ; Myocardium/metabolism ; Myocardium/pathology ; rho GTP-Binding Proteins/metabolism ; rhoA GTP-Binding Protein
Czasopismo naukowe
Tytuł:
MicroRNAs differentially regulated in cardiac and skeletal muscle in health and disease: potential drug targets?
Autorzy:
Winbanks CE; Baker IDI Heart and Diabetes Institute, Monash University, Melbourne, Vic., Australia.
Ooi JY
Nguyen SS
McMullen JR
Bernardo BC
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2014 Sep; Vol. 41 (9), pp. 727-37.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Health*
Heart Diseases/*drug therapy
MicroRNAs/*genetics
MicroRNAs/*metabolism
Molecular Targeted Therapy/*methods
Muscle, Skeletal/*metabolism
Muscular Diseases/*drug therapy
Myocardium/*metabolism
Animals ; Exercise/physiology ; Heart/drug effects ; Heart/growth & development ; Heart Diseases/genetics ; Heart Diseases/metabolism ; Humans ; Muscle, Skeletal/growth & development ; Muscular Diseases/genetics ; Muscular Diseases/metabolism
Czasopismo naukowe
Tytuł:
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
Autorzy:
Bernardo BC; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Gao XM; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Tham YK; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Kiriazis H; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Winbanks CE; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Ooi JY; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Boey EJ; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Obad S; Santaris Pharma, Horsholm, Denmark.
Kauppinen S; Department of Haematology, Aalborg University Hospital, Copenhagen, Denmark.
Gregorevic P; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Du XJ; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Lin RC; Ramaciotti Centre for Genomics, School of Biotechnology & Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.
McMullen JR; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia ; Departments of Medicine Monash University, Clayton, Victoria, Australia ; Departments of Physiology, Monash University, Clayton, Victoria, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Feb 27; Vol. 9 (2), pp. e90337. Date of Electronic Publication: 2014 Feb 27 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Silencing*
Cardiomyopathy, Hypertrophic/*genetics
Cardiomyopathy, Hypertrophic/*physiopathology
MicroRNAs/*genetics
Animals ; Cardiomyopathy, Hypertrophic/pathology ; Disease Models, Animal ; Echocardiography ; Fibrosis ; Gene Expression Regulation ; Male ; Mice ; Severity of Illness Index ; Ventricular Remodeling/genetics
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies